Blog
Why Wells Fargo Stock Wilted on Wednesday
A popular payment system offered by Wells Fargo (NYSE: WFC) came under some legal fire on Wednesday, and more than a few investors scuttled out of the bank. This left the lender's stock with a 2%
Global Water Q2 Revenue Up 5.4 Percent
Global Water Resources (NASDAQ:GWRS), an Arizona-based regulated utility specializing in water, wastewater, and recycled water service, reported its second quarter 2025 earnings on August 13, 2025
Strata Skin Sciences Sales Decline
Strata Skin Sciences (NASDAQ:SSKN), a medical technology firm specializing in dermatology devices, reported its second quarter 2025 earnings on August 13, 2025. The company reported GAAP revenue of
Why Lemonade Stock Raced More Than 9% Higher Today
The stock market was hardly sour on Lemonade (NYSE: LMND) stock on Wednesday. On the back of two positive analysts moves on the next-generation insurer, its share price zoomed to an over 9% gain
3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever
The past several months have been bullish ones for the market. But not for every stock. Even some of the S&P 500's (SNPINDEX: ^GSPC) seemingly safe dividend stocks have been upended, even if only
Ainos Posts Wider Loss in Fiscal Q2
Ainos (NASDAQ:AIMD), a biotechnology innovator focused on digital health and diagnostics, released its second quarter 2025 results on August 13, 2025. For Q2 2025, revenue was $4,663 and gross
StandardAero Ups Guidance on Earnings
StandardAero(NYSE:SARO) released results for the fiscal second quarter ended June 30, 2025, on August 13, 2025, revealing revenue grew 13.5% year-over-year to $1.53 billion, and adjusted EBITDA
DLocal Q2 Profit Jumps on Strong Growth
DLocal(NASDAQ:DLO) reported second-quarter 2025 results on August 13, 2025, with total payment volume (TPV) up 53% year over year to $9.2 billion, revenue up 50% year over year to $256 million, and
Coherent Posts Record Q4 Revenue
Coherent (NYSE:COHR) reported fiscal fourth quarter ended June 30, 2025, earnings on August 13, 2025, reporting record revenue of $1.53 billion in the fiscal fourth quarter, up 16% year-over-year
Ensysce Biosciences Narrows Loss in Q2
Ensysce Biosciences (NASDAQ:ENSC), a biotechnology company developing abuse-deterrent opioid therapies, reported its second-quarter results on August 13, 2025. The quarter’s biggest news included
Lantern Pharma Narrows Loss in Q2
Lantern Pharma (NASDAQ:LTRN), a biotech focused on AI-enabled precision oncology, released its earnings for the quarter ended June 30, 2025, on August 13, 2025. Lantern Pharma reported a GAAP net
CaliberCos (CWD) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 5 p.m. ET
Chief Executive Officer — Chris Loeffler
Source Fool.com
Enliven Posts Loss Beat and Cash Surge
Enliven Therapeutics (NASDAQ:ELVN), a clinical-stage biotechnology company focused on cancer therapies, reported its second quarter 2025 results on August 13, 2025. The release highlighted a net
Dyadic International Narrows Q2 Loss
Dyadic International (NASDAQ:DYAI) reported Q2 2025 earnings on August 13, 2025, delivering GAAP revenue of $967,000, representing a year-over-year increase over Q2 2024 and the company’s clearest
Applied Therapeutics Reports Q2 Loss
Applied Therapeutics (NASDAQ:APLT), a biotechnology company focused on developing treatments for rare metabolic diseases, reported earnings results for Q2 2025 on August 13, 2025. The main news from
Ibotta Posts 2 Percent Sales Decline
Ibotta (NYSE:IBTA), a leading digital promotions and performance marketing platform for consumer packaged goods (CPG), released financial results for Q2 2025 on August 13, 2025. The most notable
Allogene Q2 Cash Tops $300 Million
Allogene Therapeutics (NASDAQ:ALLO) reported second-quarter 2025 results on August 13, 2025, highlighting $302.6 million in cash and investments as of the end of Q2 2025 with a projected cash runway
Dyadic (DYAI) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 5:00 p.m. ET
President and Chief Operating Officer — Joe Hazelton
Source Fool.com
Natural Gas Services Group Beats Q2 EPS
Natural Gas Services Group (NYSE:NGS), a provider of natural gas compression equipment rentals and services, Natural Gas Services Group released its financial results for Q2 FY2025 on August 11
Acrivon Posts Narrower Loss in Q2
Acrivon Therapeutics (NASDAQ:ACRV), a clinical-stage biotech developing precision oncology medicines, released its second quarter 2025 results on August 13, 2025. The report showed a GAAP net loss
Spire Global Posts Debt Free Q2 Results
Spire Global (NYSE:SPIR) reported preliminary Q2 2025 GAAP revenue of $18 million to $19 million, following the transformative sale of its maritime business and full elimination of company debt
Dolphin Revenue Jumps 23 Percent
Dolphin Entertainment (NASDAQ:DLPN), a diversified entertainment marketing and content production company, released its second quarter 2025 results on August 13, 2025. The headline news was a record
Oncology Institute TOI Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 5 p.m. ET
Chief Executive Officer — Daniel Virnich
Source Fool.com
Tenax Posts Wider Loss in Fiscal Q2
Tenax Therapeutics (NASDAQ:TENX), a development-stage biopharmaceutical company focused on treatments for cardiovascular and pulmonary diseases, released its results for the second quarter of fiscal
SurgePays Lifeline Activations Jump
SurgePays (NASDAQ:SURG) reported its fiscal Q2 2025 earnings on August 5, 2025 (for the quarter ended June 30, 2025), with revenue rose 8.9% quarter over quarter to $11.5 million and issued revenue